
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Predicted impact of the viral mutational landscape on the cytotoxic response against SARS-CoV-2
Anna Foix, Daniel López, Francisco Díez‐Fuertes, et al.
PLoS Computational Biology (2022) Vol. 18, Iss. 2, pp. e1009726-e1009726
Open Access | Times Cited: 13
Anna Foix, Daniel López, Francisco Díez‐Fuertes, et al.
PLoS Computational Biology (2022) Vol. 18, Iss. 2, pp. e1009726-e1009726
Open Access | Times Cited: 13
Showing 13 citing articles:
The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection
Christina M. Arieta, Yushu Joy Xie, Daniel Rothenberg, et al.
Cell (2023) Vol. 186, Iss. 11, pp. 2392-2409.e21
Open Access | Times Cited: 57
Christina M. Arieta, Yushu Joy Xie, Daniel Rothenberg, et al.
Cell (2023) Vol. 186, Iss. 11, pp. 2392-2409.e21
Open Access | Times Cited: 57
OMICRON: Virology, immunopathogenesis, and laboratory diagnosis
Mahsa Bazargan, Reza Elahi, Abdolreza Esmaeilzadeh
The Journal of Gene Medicine (2022) Vol. 24, Iss. 7
Open Access | Times Cited: 42
Mahsa Bazargan, Reza Elahi, Abdolreza Esmaeilzadeh
The Journal of Gene Medicine (2022) Vol. 24, Iss. 7
Open Access | Times Cited: 42
Defending against SARS-CoV-2: The T cell perspective
Patricia Almendro-Vázquez, Rocío Laguna‐Goya, Estela Paz‐Artal
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 36
Patricia Almendro-Vázquez, Rocío Laguna‐Goya, Estela Paz‐Artal
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 36
Safety and efficacy of convalescent plasma for severe COVID-19: a randomized, single blinded, parallel, controlled clinical study
Manuel Rojas, Yhojan Rodríguez, Juan C. Hernández, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 15
Manuel Rojas, Yhojan Rodríguez, Juan C. Hernández, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 15
Advances of Nanotechnology Toward Vaccine Development Against Animal Infectious Diseases
Xinlian Wang, Xinglong Gao, Liuxiang Wang, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 46
Open Access | Times Cited: 7
Xinlian Wang, Xinglong Gao, Liuxiang Wang, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 46
Open Access | Times Cited: 7
Large libraries of single-chain trimer peptide-MHCs enable antigen-specific CD8+ T cell discovery and analysis
William Chour, Jongchan Choi, Jingyi Xie, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 5
William Chour, Jongchan Choi, Jingyi Xie, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 5
Early protective effect of a (“pan”) coronavirus vaccine (PanCoVac) in Roborovski dwarf hamsters after single-low dose intranasal administration
Mohammed O. Abdelaziz, Martin Raftery, Julian Weihs, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Mohammed O. Abdelaziz, Martin Raftery, Julian Weihs, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Physicochemical properties-based hybrid machine learning technique for the prediction of SARS-CoV-2 T-cell epitopes as vaccine targets
Syed Nisar Hussain Bukhari, E. Elshiekh, Mohamed Abbas
PeerJ Computer Science (2024) Vol. 10, pp. e1980-e1980
Open Access | Times Cited: 1
Syed Nisar Hussain Bukhari, E. Elshiekh, Mohamed Abbas
PeerJ Computer Science (2024) Vol. 10, pp. e1980-e1980
Open Access | Times Cited: 1
A systems approach evaluating the impact of SARS-CoV-2 variant of concern mutations on CD8+ T cell responses
Paul Buckley, Chloe H. Lee, Agne Antanaviciute, et al.
Immunotherapy Advances (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 3
Paul Buckley, Chloe H. Lee, Agne Antanaviciute, et al.
Immunotherapy Advances (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 3
As the virus evolves, so too must we: a drug developer’s perspective
Fang Fang
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 5
Fang Fang
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 5
Bioinformatic Tools for Studying the Cellular Immune Response to SARS-CoV-2, Vaccine Efficacy, and Future Pandemics at the Global Population Level
Daniel López, Javier Zumárraga
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13477-13477
Open Access
Daniel López, Javier Zumárraga
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13477-13477
Open Access
A systems approach evaluating the impact of SARS-CoV-2 variant of concern mutations on CD8+ T cell responses
Paul Buckley, Chloe H. Lee, Agne Antanaviciute, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Paul Buckley, Chloe H. Lee, Agne Antanaviciute, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Large libraries of single-chain trimer peptide-MHCs enable rapid antigen-specific CD8+ T cell discovery and analysis
James R. Heath, William Chour, Jongchan Choi, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
James R. Heath, William Chour, Jongchan Choi, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1